Table 1 Baseline characteristics of respondents.

From: Postoperative quality of life in patients treated for thyroid cancer with transoral endoscopic and open surgery

Variables

Total (n = 221)

Open surgery (n = 136)

TOETVA (n = 85)

P

Age, mean ± SD

44.21 ± 12.25

47.85 ± 12.02

38.39 ± 10.26

< 0.001

BMI, mean ± SD

23.53 ± 3.18

23.47 ± 3.02

23.63 ± 3.45

0.710

Tumor max diameter, M (Q₁, Q₃)

0.70 (0.40, 1.00)

0.70 (0.50, 1.00)

0.70 (0.40, 1.00)

0.932

Surgery time, M (Q₁, Q₃)

120.00 (95.00, 170.00)

103.00 (81.50, 120.25)

185.00 (149.00, 229.00)

< 0.001

Hospital duration, M (Q₁, Q₃)

6.00 (5.00, 8.00)

6.00 (4.00, 8.00)

7.00 (5.00, 9.00)

0.004

Treatment costs, M (Q₁, Q₃)

18.90 (17.41, 20.52)

18.46 (17.03, 19.90)

19.89 (18.15, 21.50)

<0.001

Gender, n (%)

   

0.165

 Female

145 (65.61)

94 (69.12)

51 (60.00)

 

 Male

76 (34.39)

42 (30.88)

34 (40.00)

 

Type of thyroidectomy, n (%)

   

< 0.001

 Partial

156 (70.59)

84 (61.76)

72 (84.71)

 

 Total

65 (29.41)

52 (38.24)

13 (15.29)

 

Pathologic diagnosis, n (%)

   

0.557

 PTC

208 (94.12)

127 (93.38)

81 (95.29)

 

 FTC

13 (5.88)

9 (6.62)

4 (4.71)

 

T stage, n (%)

   

0.468

 1

212 (95.93)

132 (97.06)

80 (94.12)

 

 2

9 (4.07)

4 (2.94)

5 (5.88)

 

Nodal stage, n (%)

   

0.230

 0

124 (56.11)

72 (52.94)

52 (61.18)

 

 N1a

97 (43.89)

64 (47.06)

33 (38.82)

 

AJCC stage, n (%)

   

0.140

 1

203 (91.86)

122 (89.71)

81 (95.29)

 

 2

18 (8.14)

14 (10.29)

4 (4.71)

 

Tumor site, n (%)

   

<0 0.001

 Both right and left

36 (16.29)

32 (23.53)

4 (4.71)

 

 Isthmus

12 (5.43)

10 (7.35)

2 (2.35)

 

 Left

75 (33.94)

42 (30.88)

33 (38.82)

 

 Right

98 (44.34)

52 (38.24)

46 (54.12)

 

Hypoparathyroidism, n (%)

   

0.008

 No

191 (86.43)

111 (81.62)

80 (94.12)

 

 Yes

30 (13.57)

25 (18.38)

5 (5.88)

 

Marital, n (%)

   

0.010

 Married/live with partner

197 (89.14)

127 (93.38)

70 (82.35)

 

 Single/widowed

24 (10.86)

9 (6.62)

15 (17.65)

 

Education, n (%)

   

< 0.001

 College and above

104 (47.06)

44 (32.35)

60 (70.59)

 

 Elementary and below

32 (14.48)

29 (21.32)

3 (3.53)

 

 Junior high

52 (23.53)

40 (29.41)

12 (14.12)

 

 Senior high

33 (14.93)

23 (16.91)

10 (11.76)

 

Residence, n (%)

   

<0 0.001

 Rural

60 (27.15)

51 (37.50)

9 (10.59)

 

 Urban

161 (72.85)

85 (62.50)

76 (89.41)

 

Employment status, n (%)

   

<0 0.001

 Employed

175 (79.19)

100 (73.53)

75 (88.24)

 

 Retired

33 (14.93)

30 (22.06)

3 (3.53)

 

 Unemployed

13 (5.88)

6 (4.41)

7 (8.24)

 

Monthly household income (¥), n (%)

   

< 0.001

 < 1000

10 (4.52)

7 (5.15)

3 (3.53)

 

 > 10,000

73 (33.03)

31 (22.79)

42 (49.41)

 

 1000 ~ 3000

21 (9.50)

17 (12.50)

4 (4.71)

 

 3000 ~ 5000

46 (20.81)

36 (26.47)

10 (11.76)

 

 5000 ~ 10,000

71 (32.13)

45 (33.09)

26 (30.59)

 

Primary treatment, n (%)

   

0.124

 Surgery

215 (97.29)

130 (95.59)

85 (100.00)

 

 Surgery and RAI

6 (2.71)

6 (4.41)

0 (0.00)

 

Depress, n (%)

   

0.668

 No

26 (11.76)

15 (11.03)

11 (12.94)

 

 Yes

195 (88.24)

121 (88.97)

74 (87.06)

 

Anxiety, n (%)

   

0.083

 No

11 (4.98)

10 (7.35)

1 (1.18)

 

 Yes

210 (95.02)

126 (92.65)

84 (98.82)

 
  1. N = 221; SD standard deviation, M median, IQR interquartile range, TOETVA transoral endoscopic thyroidectomy vestibular approach, PTC papillary thyroid carcinoma, FTC follicular thyroid carcinoma, RAI radioiodine. Significant values are in bold.